Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines, by Mr Enders Ekblom
Presenting on the above topic is Mr Anders Ekblom, Executive Vice President, Global Medicines Development, Astrazeneca, Sweden. He will be speaking at Pharma Partnering & Investment World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
Mr Ekblom is responsible for R&D operating across drug development and life cycle management delivering submissions and approvals in Astrazeneca. He was also in charge of strategy, portfolio and alliances in the company. He will be discussing in our keynote panel on the views of Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines.
Mr Ekblom will be addressing the following issues:
Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines
1. Assessing the global biotech market: Where and how Asia fits into the equation
2. Leveraging on the existing strengths in Asia and identifying opportunities for growth in the lifescience sector
3. Commercializing innovation: What are the challenges and strategies in Asia